Xcorporeal, Inc. (XCRP)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 10, 2026
Xcorporeal Company Description
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010.
The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company.
Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs.
Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.
Contact Details
Address: 80 Empire Drive Lake Forest, California 92630 United States | |
| Phone | 949 600 4621 |
Stock Details
| Ticker Symbol | XCRP |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US98400P1049 |
| SIC Code | 9995 |
Key Executives
| Name | Position |
|---|---|
| Dr. Victor Gura M.D. | Chief Scientific Officer, Chief Medical Officer and Member of Board of Advisors |
| Len Braganza | Vice President of Sales and Marketing |